Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | ECE1 | P42892 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | KDM4B | O94953 | 1/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL20584909 | 1.00 | SSTR4 (0.38) | SSTR4RAB9AKDM4EPOLBGAA | |
| Trifluoroacetic Acid SCHEMBL30241438 | 0.73 | KDM5A (0.43) | POLBHTTSLC6A3SLC6A2SLC6A4 | |
| Trifluoroacetic Acid SCHEMBL25296943 | 0.73 | RAB9A (0.33) | RAB9AKDM4EPOLBGAAHTT | |
| SCHEMBL20586011 | 0.71 | RAB9A (0.38) | RAB9AKDM4EPOLBGAAHTT | |
| SCHEMBL20587746 | 0.71 | RAB9A (0.38) | RAB9AKDM4EPOLBGAAHTT | |
| SCHEMBL20586014 | 0.71 | RAB9A (0.38) | RAB9AKDM4EPOLBGAAHTT | |
| SCHEMBL20586012 | 0.71 | RAB9A (0.38) | RAB9AKDM4EPOLBGAAHTT | |
| Trifluoroacetic Acid SCHEMBL27323699 | 0.71 | RAB9A (0.38) | RAB9AKDM4EPOLBGAAHTT | |
| Trifluoroacetic Acid SCHEMBL30241469 | 0.71 | SSTR4 (0.50) | SSTR4 | |
| Trifluoroacetic Acid SCHEMBL21063424 | 0.69 | CHRNA7 (0.35) | SLC6A3SLC6A2SLC6A4CHRNA7CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3638658-B1 | PHARMACEUTICAL COMPOUNDS | NXERA PHARMA UK LTD (GB) | 2025-10-08 | — | — | EP | disclosed |
| CN-110944992-B | Pharmaceutical compounds | 赫普泰雅治疗有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-11352342-B2 | Pharmaceutical compounds | HEPTARES THERAPEUTICS LIMITED (GB) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352342-B2 | Pharmaceutical compounds | CHRM1, CHRM2, CHRM4 | SSTR4 391/4885RAB9A 1785/4885KDM4E 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.